OBERBAUER R, HUTCHISON B, ERIS J, ARIAS M, CLAESSON K, MOTA A, KREI...

6.

Oberbauer R, Hutchison B, Eris J, Arias M, Claesson K, Mota A, Kreis

ance. Such strategies would include more support from all

H, Kleinman L, Wang F, Chen J, Revicki DA: Health-related qual-

members of a transplant team and also shorter follow-up

ity-of-life outcomes of sirolimus-treated kidney transplant

intervals as outpatient to check the immunosuppressive

patients after elimination of cyclosporine A: results of a 2-

year randomized clinical trial.

Transplantation 2003,

trough levels more frequently than in compliant patients.